blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2212290

EP2212290 - ARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.10.2015
Database last updated on 14.11.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, HU, MT, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston, MA 02210 / US
[2014/35]
Former [2014/09]For all designated states
Vertex Pharmaceuticals Inc.
50 Northern Avenue
Boston, MA 02210 / US
Former [2010/31]For all designated states
Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, MA 02139 / US
Inventor(s)01 / CHEN, Weichuan, Caroline
7559 Hazard Center Drive
San Diego CA 92108 / US
02 / KRENITSKY, Paul
11045 Alonda Court
San Diego CA 92126 / US
03 / TERMIN, Andreas
2080 Wandering Road
Encinitas CA 92024 / US
04 / WILSON, Dean
242 Old Billerica Rd.
Bedford MA 01730 / US
05 / JOSHI, Pramod
13023 Old West Avenue
San Diego CA 92129 / US
 [2010/31]
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstraße 14
40211 Düsseldorf / DE
[N/P]
Former [2014/49]Cohausz & Florack
Patent- und Rechtsanwälte
Partnerschaftsgesellschaft
Bleichstraße 14
40211 Düsseldorf / DE
Former [2010/31]Cohausz & Florack
Patent- und Rechtsanwälte Partnerschaftsgesellschaft Bleichstraße 14
40211 Düsseldorf / DE
Application number, filing date08838261.910.10.2008
[2010/31]
WO2008US79546
Priority number, dateUS20070979289P11.10.2007         Original published format: US 979289 P
[2010/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009049183
Date:16.04.2009
Language:EN
[2009/16]
Type: A1 Application with search report 
No.:EP2212290
Date:04.08.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 16.04.2009 takes the place of the publication of the European patent application.
[2010/31]
Type: B1 Patent specification 
No.:EP2212290
Date:03.12.2014
Language:EN
[2014/49]
Search report(s)International search report - published on:EP16.04.2009
ClassificationIPC:C07D213/65, C07D213/643, C07C233/64, A61K31/33, A61P19/02
[2010/31]
CPC:
C07D213/65 (EP,US); A61P1/00 (EP); A61P13/10 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/08 (EP); A61P25/14 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/06 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07C237/42 (EP,US); C07C311/08 (EP,US);
C07C317/40 (EP,US); C07D213/643 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/31]
TitleGerman:ALS INHIBITOREN VON SPANNUNGSABHÄNGIGEN NATRIUMKANÄLEN GEEIGNETE ARYLAMIDE[2010/31]
English:ARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS[2010/31]
French:ARYL AMIDES UTILES EN TANT QU'INHIBITEURS DE CANAUX SODIQUES SENSIBLES AU VOLTAGE[2010/31]
Entry into regional phase10.05.2010National basic fee paid 
10.05.2010Designation fee(s) paid 
10.05.2010Examination fee paid 
Examination procedure10.05.2010Examination requested  [2010/31]
12.07.2010Amendment by applicant (claims and/or description)
17.07.2013Communication of intention to grant the patent
13.11.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.05.2014Communication of intention to grant the patent
01.10.2014Fee for grant paid
01.10.2014Fee for publishing/printing paid
01.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.07.2013
Opposition(s)04.09.2015No opposition filed within time limit [2015/46]
Fees paidRenewal fee
25.10.2010Renewal fee patent year 03
25.10.2011Renewal fee patent year 04
25.10.2012Renewal fee patent year 05
28.10.2013Renewal fee patent year 06
27.10.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Rights in Rem or Legal Means of ExecutionID:01
For:AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Date:31.10.2014
[2014/51]
Lapses during opposition  TooltipHU10.10.2008
AT03.12.2014
BE03.12.2014
BG03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
IT03.12.2014
LT03.12.2014
LV03.12.2014
MC03.12.2014
MT03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SI03.12.2014
SK03.12.2014
TR03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
[2017/39]
Former [2016/28]AT03.12.2014
BE03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
IT03.12.2014
LT03.12.2014
LV03.12.2014
MC03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SI03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2016/24]AT03.12.2014
BE03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
IT03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SI03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2016/12]AT03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
IT03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SI03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2016/03]AT03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
IT03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2015/50]AT03.12.2014
CY03.12.2014
CZ03.12.2014
DK03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2015/38]AT03.12.2014
CY03.12.2014
CZ03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
IS03.04.2015
PT03.04.2015
Former [2015/37]AT03.12.2014
CY03.12.2014
CZ03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
PL03.12.2014
RO03.12.2014
SE03.12.2014
SK03.12.2014
NO03.03.2015
GR04.03.2015
PT03.04.2015
Former [2015/36]AT03.12.2014
CY03.12.2014
CZ03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
RO03.12.2014
SE03.12.2014
NO03.03.2015
GR04.03.2015
PT03.04.2015
Former [2015/35]AT03.12.2014
CY03.12.2014
EE03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
SE03.12.2014
NO03.03.2015
GR04.03.2015
PT03.04.2015
Former [2015/26]AT03.12.2014
CY03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
SE03.12.2014
NO03.03.2015
GR04.03.2015
Former [2015/25]AT03.12.2014
ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
SE03.12.2014
NO03.03.2015
GR04.03.2015
Former [2015/24]ES03.12.2014
FI03.12.2014
HR03.12.2014
LT03.12.2014
LV03.12.2014
NL03.12.2014
SE03.12.2014
NO03.03.2015
GR04.03.2015
Former [2015/23]ES03.12.2014
FI03.12.2014
LT03.12.2014
NL03.12.2014
NO03.03.2015
Former [2015/21]LT03.12.2014
NO03.03.2015
Former [2015/20]LT03.12.2014
Cited inInternational search[A]WO2005013914  (VERTEX PHARMA [US], et al) [A] 1,17-20* abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.